They are regulatory cells capable of inhibiting allogeneic responses through HLA-G and IL-10, of inducing IL-10-producing T regulatory type 1 (Tr1) cells (42, 43), and they were shown to increase in cancer patients (53, 54). The gene discussed is IL10; the disease is cancer.